s141
THE EXPRESSION
235
PRIMARY
JUNK1 YAMAMOTO, NAM1 KAWAGUCHI Department
OF CXC AND CC CHEMOKINE
CULTURED
MICROGLIA,
ASTROCYTE
MASABUMI MINAMI, ATSUSHI and MASAMICHI SATOH
of Molecular
Pharmacology,
RECEPTOR mRNAs IN RAT
NISHIYORI,
Faculty of Pharmaceutical
AND NEURON. SHINYA TAKAMI,
Sciences,
YOSHIKAZU
Kyoto University,
Sakyo-ku,
OHTANI,
Kyoto 606-8501
CINC- 1, which is the member of CXC chernokine family, decreased the nocice-
Previously, we reported that intracerebroventricular
ptive threshold to mechanical stimuli and that the expression of the mRNAs for MCP-I and MIP-lc(, which are belonged to the CC chemokine family, were induced on glial cells after focal cerebral ischemia in the rat. However, the cellular sources of CXC and CC chemokine receptors (CXCRs and CCRs) are unknown. chemokine polymerase
receptors
In this study, we examined the expression of the mRNAs for CXC and CC
(CXCRs and CCRs) in rat primary cultured microglia, astrocytes
chain reaction (RT-PCR) technique.
subtypes of CCRs from rat brain.
and neuron by a reverse transcription
-
Firstly, we cloned the partial cDNAs for three subtypes of CXCRs and five
Next, we designed primer sets for each receptors based on the obtained partial cDNAs, and made
it possible to examine the expression of CXCR and CCR mRNAs by RT-PCR. The mRNAs for CXCR- I, 2.4 were expressed in rat primary cultured microglia, astrocytes and neuron.
While, the CCR mRNAs showed the various expression patterns in these cells.
These results suggest that the responses of the brain cells to the chemokines differ with cell types.
236
PERlNEURONAL
GLIAL PLEXUSES
PROTEOGLYCAN
AND A SUBSET OF GABAERGIC
CONTAINING
NEUROCANNEURONS
I?(, AND/OR PHOSPHACAN!hB4 IN THE CEREBRAL
CORTEX OF
ADULT RATS. MASAKONISHIZUKA’, ‘Departmentof
ATSUHIKO
Anatomy, Juntendo Umverslt> School of Medlclne, Bunkyo-ku,
‘Department of Perinatologq, Neurocan,
Its C-fragment
variant of receptor-type three antibodies, cell processes
Institute for Developmental
(neurocan-C)
and N-fragment
protein phosphatase
(neurtxan-130),
and phosphacan
and neurocan-130,
but not neurocan-C.
four types of penneuronal
GABAergic neruons immunoreactive
to anti-parlalbumm
an e\tracellular Using dtfferenr
in the c)-toplasm of ghal
Based on co-localization
of neurtran-
glial plexuses are distingulshed
containing glial plexuses; phosphacan-containing
we report, type of proteoglycan(s)
(tiB4 proteoglycan,
of neural proteoglycans.
plexuses; the remaining that are not clearly Immunoreactl\‘e
In this presentation,
237
Kasugal, Alchi 480-0303
(RF’TPP) are major components
m the cytoplasm of glial cell processes,
co-localized
Tok1.o I 13-842 1,
the cell bodies and proximal dendrites of a subset of neurons.
cerebral cortex of adult rats: neurocan-130 phosphacan
mPc
Research,
we have shown distribution of phosphacan
enwrapping
130 and phosphacan
antibodies.
OOHIRA ’
In the
plexuses; neurocan- I30 and
to the ant]-neurocan/phosphacan
contamed in the perineuronal
ghal pie\-uses of a subset of
antibocly In the cerebral cortex of adult rats.
KAINIC ACID-INDUCED ACTIVATION OF NUCLEAR FACTOR-KB IN THE GLIAL CELLS
YASUJI MATSUOKA ‘, MITSUHIRO OKAZAKI ‘, YOSHIHISA KITAMURA ‘, AND TAKASHI TANIGUCHI ’ ’ DEPARTMENT
OF NEUROBIOLOGY,
KYOTO PHARMACEUTICAL
UNIVERSITY, YAMASHINA,
KYOTO
607-8412 Nuclear factor-& (NF-KB) is known to play a key role in immune and inflammatory responses. It is known that inflammatory activation was occurred by neuronal damage. To understand the mechanisms of inflammatory activation which accompanies neuronal damage, we determined the cell type in which NF-KB was activated. NF-KB protein was detected in the cytosolic fraction in untreated and vehicle-treated rat hippocampus. After kainic acid (KA) treatment, NF-KB protein was significantly increased in both the cytosolic and particulate fractions. NF-KB-immunoreactivity was observed in both brain blood vessels and glial cells after 1 day. Although NF-KB-immunoreactivity in brain blood vessels disappeared after 3 days, this activity was maintained in glial cells for up to 7 days. In addition, double immunostaining indicate that NF-KB was activated in both glial cells such as microglia and astrocytes after 3 days. Thus, NF-KB activation seems to occur delayed and continuously in microglia and astrocytes, suggesting that an inflammatory activation in glial cells participates with KA-induced neurodegeneration.